Safeguard Scientifics, Inc.
SFES · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.84 | 0.04 | 0.02 | -0.03 |
| FCF Yield | -20.77% | -26.15% | -6.43% | -5.59% |
| EV / EBITDA | -0.83 | -0.46 | -2.79 | 4.52 |
| Quality | ||||
| ROIC | -24.70% | -26.71% | -13.15% | -13.58% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.29 | 0.34 | 0.23 | -0.30 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 10.01% | -1.53% | 60.03% | -0.11% |
| Safety | ||||
| Net Debt / EBITDA | 0.60 | 0.87 | 0.83 | -0.83 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -122.43 | -21.55 | -65.35 |